METROPOLIS

Metropolis Healthcare Share Price

₹1,652.50 -25.6 (-1.53%)

22 Feb, 2025 23:27

SIP TrendupStart SIP in METROPOLIS

Start SIP

Performance

  • Low
  • ₹1,629
  • High
  • ₹1,686
  • 52 Week Low
  • ₹1,551
  • 52 Week High
  • ₹2,318
  • Open Price₹1,683
  • Previous Close₹1,678
  • Volume167,017

Investment Returns

  • Over 1 Month -10.49%
  • Over 3 Month -18.02%
  • Over 6 Month -21.15%
  • Over 1 Year -4.47%
SIP Lightning

Smart Investing Starts Here Start SIP with Metropolis Healthcare for Steady Growth!

Invest Now

Metropolis Healthcare Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 55.7
  • PEG Ratio
  • 2.5
  • Market Cap Cr
  • 8,474
  • P/B Ratio
  • 7.2
  • Average True Range
  • 60.8
  • EPS
  • 29.69
  • Dividend Yield
  • 0
  • MACD Signal
  • -60
  • RSI
  • 32.43
  • MFI
  • 34.17

Metropolis Healthcare Financials

Metropolis Healthcare Technicals

EMA & SMA

Current Price
₹1,652.50
-25.6 (-1.53%)
pointer
  • stock-down_img
  • Bullish Moving Average 0
  • stock-up_img
  • Bearish Moving Average 16
  • 20 Day
  • ₹1,744.58
  • 50 Day
  • ₹1,857.04
  • 100 Day
  • ₹1,943.50
  • 200 Day
  • ₹1,947.58

Resistance and Support

1655.9 Pivot Speed
  • R3 1,739.70
  • R2 1,712.90
  • R1 1,682.70
  • S1 1,625.70
  • S2 1,598.90
  • S3 1,568.70

What's your outlook on Metropolis Healthcare?

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Metropolis Healthcare Ltd. is a leading diagnostic service provider in India, offering a wide range of pathology tests and healthcare solutions. With an extensive network of labs and collection centers, it serves patients across India and international markets.

Metropolis Healthcare has an operating revenue of Rs. 1,316.91 Cr. on a trailing 12-month basis. An annual revenue growth of 5% is not great, Pre-tax margin of 14% is healthy, ROE of 11% is good. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 56 which is a POOR score indicating inconsistency in earnings, a RS Rating of 40 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at C which is evident from recent supply seen, Group Rank of 79 indicates it belongs to a poor industry group of Medical-Services and a Master Score of C is fair but needs to improve. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Metropolis Healthcare Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-02-04 Quarterly Results
2024-12-09 Preferential issue of shares Inter-alia to consider : 1. Issuance of equity shares of the Company on a preferential basis, in accordance with the applicable laws, subject to the approval of shareholders of the Company. per share(400%)Interim Dividend
2024-11-08 Quarterly Results
2024-08-10 Quarterly Results
2024-05-21 Audited Results
Date Purpose Remarks
2023-11-17 INTERIM Rs.4.00 per share(200%)Interim Dividend
2023-02-23 INTERIM Rs.8.00 per share(400%)Interim Dividend (Revised)
2022-02-22 INTERIM Rs.8.00 per share(400%)Interim Dividend
2021-02-19 INTERIM Rs.8.00 per share(400%)Interim Dividend

Metropolis Healthcare F&O

Metropolis Healthcare Shareholding Pattern

49.4%
26.37%
3.5%
16.73%
3.34%
0.66%

About Metropolis Healthcare

  • NSE Symbol
  • METROPOLIS
  • BSE Symbol
  • 542650
  • Managing Director
  • Mrs. Ameera Sushil Shah
  • ISIN
  • INE112L01020

Similar Stocks to Metropolis Healthcare

Metropolis Healthcare FAQs

Metropolis Healthcare share price is ₹1,652 As on 22 February, 2025 | 23:13

The Market Cap of Metropolis Healthcare is ₹8474.2 Cr As on 22 February, 2025 | 23:13

The P/E ratio of Metropolis Healthcare is 55.7 As on 22 February, 2025 | 23:13

The PB ratio of Metropolis Healthcare is 7.2 As on 22 February, 2025 | 23:13

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23